Home

Zai Lab Announces Participation in Investor Conferences in March 2025

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in March 2025:

Leerink Partners 2025 Global Healthcare Conference

Fireside Chat: Monday, March 10, 2025, 9:20 a.m. EST

Location: Miami, FL

Jefferies Biotech on the Beach Summit

Time: Tuesday, March 11, 2025

Location: Miami, FL

A live webcast of the fireside chat will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and archived replay will be available for up to 90 days following the completion of the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.X.com/ZaiLab_Global.

Contacts